-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M/H1JoNRiAJf2kyRCbH7BT2WvHOcrMLFke7kIdiwoHXo58yZEvGgQtoLDUDdFd5E 1mOnPsHA79IDa8oZ0wu5fQ== 0001104659-08-025469.txt : 20080421 0001104659-08-025469.hdr.sgml : 20080421 20080421102940 ACCESSION NUMBER: 0001104659-08-025469 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080415 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20080421 DATE AS OF CHANGE: 20080421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMS HEALTH INC CENTRAL INDEX KEY: 0001058083 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 061506026 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14049 FILM NUMBER: 08765858 BUSINESS ADDRESS: STREET 1: 901 MAIN AVENUE STREET 2: SUITE 612 CITY: NORWALK STATE: CT ZIP: 06851 BUSINESS PHONE: 2038455200 MAIL ADDRESS: STREET 1: 901 MAIN AVENUE STREET 2: SUITE 612 CITY: NORWALK STATE: CT ZIP: 06851 8-K 1 a08-11859_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported)  April 15, 2008

 

IMS HEALTH INCORPORATED

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-14049

 

06-1506026

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

901 Main Avenue, Norwalk, Connecticut

 

06851

(Address of Principal Executive Offices)

 

(Zip Code)

 

(203) 845-5200

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

ITEM 5.02. Compensatory Arrangements of Certain Officers

 

On April 15, 2008, IMS Health Incorporated (the “Company”) granted stock appreciation rights exercisable for stock (“SARs”) to named executive officers as follows:

 

Name and Title

 

Number of SARs Granted

 

 

 

 

 

David R. Carlucci

 

154,826

 

Chairman, Chief

 

 

 

Executive Officer

 

 

 

and President

 

 

 

 

 

 

 

Gilles V. J. Pajot

 

85,154

 

Executive Vice President

 

 

 

and Chief Operating

 

 

 

Officer

 

 

 

 

 

 

 

Robert H. Steinfeld

 

38,706

 

Senior Vice President,

 

 

 

General Counsel and

 

 

 

Corporate Secretary

 

 

 

 

 

 

 

Leslye G. Katz

 

35,063

 

Senior Vice President

 

 

 

and Chief Financial

 

 

 

Officer

 

 

 

 

The exercise price of the SARs is $22.58 per share, which was the average of the high and low sales prices of Company common stock in consolidated trading of New York Stock Exchange-listed securities on the date of grant.  The SARs expire on April 15, 2015, subject to earlier expiration in certain cases at or following termination of the executive’s employment.  The SARs vest and become exercisable as to 25% of the underlying shares on each of the first four anniversaries of the date of grant, subject to accelerated vesting in certain cases, including upon a Change in Control (as defined) of the Company, upon the termination of the executive’s employment due to death or disability, and, in the case of Messrs. Carlucci, Pajot and Steinfeld, upon termination by the Company not for cause or termination by the executive for defined good reason.  SARs were granted representing approximately 50% of the value of each named executive officer’s aggregate 2008 long-term incentive award.

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

IMS Health Incorporated

 

(Registrant)

 

 

 

 

By:

/s/ Robert H. Steinfeld

 

Name:

Robert H. Steinfeld

 

Title:

Senior Vice President, General
Counsel and Corporate Secretary

Date: April 21, 2008

 

 

 

3

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----